Cheyne Capital Management (UK)’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-202,000
Closed -$1.41M 39
2022
Q4
$1.41M Sell
202,000
-51,072
-20% -$525K 2.47% 10
2022
Q3
$2.25M Buy
253,072
+66,548
+36% +$768K 4.82% 7
2022
Q2
$1.93M Buy
186,524
+5,108
+3% +$75.9K 1.63% 20
2022
Q1
$3.78M Sell
181,416
-5,910
-3% -$129K 2.38% 9
2021
Q4
$4.79M Buy
187,326
+6,925
+4% +$191K 3.12% 5
2021
Q3
$5.69M Sell
180,401
-120,396
-40% -$4.17M 3.39% 6
2021
Q2
$12M Sell
300,797
-1,912
-0.6% -$77.7K 5.48% 3
2021
Q1
$12.8M Buy
+302,709
New +$14M 8.14% 1

Other funds holding MSOS

Cheyne Capital Management (UK)'s MSOS Position: Q1 2023 in Review

Cheyne Capital Management (UK) sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q1 2023, closing a stake of 202,000 shares — an estimated $1.41M sold.

Cheyne Capital Management (UK) first reported a position in MSOS in Q1 2021 and held it in 8 quarters. The position peaked at $12.8M in Q1 2021. 175 funds tracked by Wall St. Rank hold MSOS as of Q1 2023.

  • Cheyne Capital Management (UK) reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q1 2023 after selling out during the quarter.
  • Cheyne Capital Management (UK) sold 202,000 AdvisorShares Pure US Cannabis ETF shares in Q1 2023, an estimated $1.41M.
  • Cheyne Capital Management (UK) first reported a position in AdvisorShares Pure US Cannabis ETF in Q1 2021 and held it in 8 quarters.
  • Cheyne Capital Management (UK)'s AdvisorShares Pure US Cannabis ETF position peaked at $12.8M in Q1 2021.
  • 175 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q1 2023.

Based on Cheyne Capital Management (UK)'s 13F filing for Q1 2023, filed 3 May 2023.